$AHR

Foster Mark E. sold $97K of AHR

Foster Mark E. (EVP, GC & Secretary) sold 2,000 shares of American Healthcare REIT, Inc. (AHR) at $48.32 on 2026-06-01 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Foster Mark E.
Published Jun 3, 2026, 4:00 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 6, 2026, 9:22 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$AHR
Neutral
high confidence
Mentioned
$AHR
Relevance
2/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$AHRNeutralLow
01

Why it matters

An officer-level open-market sale occurred on 2026-06-01 at $48.32/share, with holdings after the sale of 55,495 shares, under a pre-arranged 10b5-1 plan.

02

Market read

Traders may note insider selling, but the 10b5-1 structure and lack of fundamental updates make this more of a sentiment datapoint than a catalyst.

03

What to watch

The article provides only the sale details; it does not include any concurrent buys, changes in compensation, or new company performance information that would better explain directional risk.

Relevance 2/10Novelty 3/10Timing: filed 2026-06-03, transaction dated 2026-06-01

Background

The article is a SEC Form 4 insider transaction disclosure for American Healthcare REIT, Inc.

Company-level read

Ticker impact

$AHRNeutralHigh confidence
Context

American Healthcare REIT disclosed an EVP, GC & Secretary open-market sale of 2,000 shares at $48.32 under a 10b5-1 plan.

Expected impact

Likely minimal immediate price impact; any effect is more sentiment than fundamentals.

Evidence & confidence

The filing is a Form 4 insider transaction, but it specifies a pre-arranged 10b5-1 plan and an open-market sale, which typically reduces interpretive weight versus discretionary selling.

Market effects

No clear sector read-through; this is company-specific insider trading with no operational or guidance change disclosed.

None indicated.

None indicated.

Counterpoint

The sale could be driven by diversification or tax planning rather than bearish expectations, especially given the stated 10b5-1 plan.

Key entities

  • American Healthcare REIT, Inc.

    Subject of the Form 4 insider transaction disclosure.

  • Foster Mark E.

    EVP, GC & Secretary who sold 2,000 shares.

  • 10b5-1 plan

    Pre-arranged plan that typically reduces interpretive signal of insider intent.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

Med

American Healthcare Bets Big on the Silver Tsunami

American Healthcare REIT Inc. has grown its market cap to $11.4B, up 50% in a year, driven by senior housing demand. CEO Jeff Hanson returned, overseeing $2B in 2023 acquisitions and a 2024 IPO. Q2 revenue was $674.3M, beating estimates, with 10 straight quarters of double-digit NOI growth.

$AHRHighAI 9/10

Term Partnership' After $572M Portfolio Acquisition

American Healthcare REIT (AHR) acquired six senior living communities from Kensington Senior Living for $572M. The deal includes 464 units, with two more communities expected to close by Q4. AHR plans $2B in investments for 2026 and $675M more this year. Kensington will continue managing the properties, forming a long-term partnership.

$AHRHighAI 9/10

American Healthcare REIT acquires six senior living communities for $572m

American Healthcare REIT (AHR) acquired six senior living communities from Kensington Senior Living for $572m. The properties, totaling 464 units, are in major U.S. metro areas. Two more communities are expected to close in Q4 2026. The total portfolio includes 745 units, 93% for assisted living and memory care. AHR's year-to-date investments exceed $2bn. Kensington noted AHR was not the highest bidder.

$WELLMed

5 reasons to stay bullish on these dividend-paying assets, according to Morgan Stanley

Morgan Stanley's Ronald Kamdem expects senior housing REITs to continue outperforming due to aging population and high demand. Welltower (WELL) and American Healthcare REIT (AHR) are rated overweight, with price targets of $251 and implied upside, respectively. Ventas (VTR) is rated equal weight. All three REITs show strong occupancy and acquisition growth potential, with Welltower's dividend yield at 1.44%.